Targeting Zinc finger CCCH-type containing 12A (ZC3H12A), which encodes the ribonuclease REGNASE-1 was revealed to program long-lived effector T cells for cancer therapy by screening with a metabolic library targeting 3,017 genes(Wei et al., 2019). This evidence concerns the gene ZC3H12A and cancer.